SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Clinical trials for SYSTEMIC LUPUS ERTHEMATOSUS (SLE) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERTHEMATOSUS (SLE) trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERTHEMATOSUS (SLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell attack on lupus: first human trial launches
Disease control Not yet recruitingThis early-stage trial tests a new treatment called KN5501 for adults with moderate to severe lupus that hasn't responded to standard therapies. The treatment uses specially engineered immune cells (CAR-NK cells) to target and destroy faulty B cells that drive the disease. The ma…
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE1 • Sponsor: Ruitherapeutics Co., LTD • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Lupus study targets hidden immune trigger to tame blood pressure
Knowledge-focused Not yet recruitingThis study tests whether a supplement called 2-HOBA can help people with lupus by lowering blood pressure and reducing immune system overactivity. About 42 adults with stable lupus and mildly high blood pressure will take either 2-HOBA or a placebo for 4 weeks, then switch after …
Matched conditions: SYSTEMIC LUPUS ERTHEMATOSUS (SLE)
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC